Skip to content
Medical Health Aged Care

IBMI SNQ and ICHOM Forms Strategic Partnership in Asia, Advancing Patient-centered Healthcare in the Region

The Institute for Biotechnology and Medicine Industry 2 mins read
TAIPEI, Taiwan--BUSINESS WIRE--

The Symbol of National Quality (SNQ), initiated by Taiwan’s Institute for Biotechnology and Medicine Industry (IBMI), has partnered with the International Consortium for Health Outcomes Measurement (ICHOM) to set a new benchmark for healthcare standards across the Asia-Pacific region.

The partnership agreement, signed by Chen Wei-Jao, Chief Convener, SNQ Committee, and Jennifer L. Bright, President and CEO of ICHOM, marked a significant collaboration between IBMI SNQ and ICHOM.

IBMI SNQ has implemented a rigorous three-stage review system that emphasizes structure, process, and outcomes in recognizing medical teams with world-class achievements. These include liver transplantation, pancreatic cancer surgery, craniofacial reconstruction, atrial fibrillation care, critical care, and gene therapies for rare diseases. Such accomplishments have positioned Taiwan as a global benchmark for healthcare quality, with several treatment protocols adopted into textbooks and incorporated into revisions of international standard treatment guidelines.

Since its founding in 1998, IBMI SNQ has completed more than 2,900 cross-disciplinary certifications spanning specialized medical care, clinical services, management, nursing, long-term care, and community services.

ICHOM is an international non-profit organization which defines the outcomes that are most important to patients. Its Accreditation program is designed to recognize institutions that are leading the way in outcomes measurement and value-based healthcare transformation. Accreditation not only highlights excellence in clinical performance but also fosters transparency, patient-centered care, and continuous improvement. As part of this partnership, IBMI will promote the ICHOM Accreditation program throughout the country.

IBMI SNQ has played a pivotal role in advancing healthcare quality across the Asia-Pacific region as it fostered dialogues among distinguished leaders and institutions. Notable participants include Dr. David Bates, member of the Board of Experts for Newsweek World’s Best Hospitals 2025, and Jennifer L. Bright, President and CEO of ICHOM, together with representatives from renowned organizations such as the University of Tokyo Hospital, Singapore General Hospital, Stanford University, the European Union of Private Hospitals, the World Medical Association, and leading medical centers in Taiwan.

About IBMI SNQ

The Institute for Biotechnology and Medicine Industry (IBMI) administers the Symbol of National Quality (SNQ) Certification Program, Taiwan’s original healthcare quality evaluation system. Since 1998, SNQ has certified thousands of healthcare services and innovations and recognized world-leading medical teams through its rigorous outcome-oriented evaluation standards.


Contact details:

Joy Wan, IBMI SNQ
Email: [email protected]

Media

More from this category

  • Government Federal, Medical Health Aged Care
  • 27/02/2026
  • 09:30
Australian College of Nursing

Senate Committee gives green light to registered nurse prescribing reform

The Senate Community Affairs Legislation Committee has recommended the passage of the Health Legislation Amendment (Prescribing of Pharmaceutical Benefits) Bill 2025, paving the way for designated registered nurses to prescribe medicines under the Pharmaceutical Benefits Scheme (PBS) from July 2026. The Australian College of Nursing welcomes the Committee’s unanimous recommendation to pass the bill, after a comprehensive inquiry that received 47 submissions from nursing organisations, medical associations, state governments, consumer groups, and individuals. The Committee found strong support for the reform across the health sector. “This is the most significant recognition of nursing’s role in Australia’s health system in a…

  • Contains:
  • Medical Health Aged Care, Science
  • 27/02/2026
  • 09:13
Centenary Institute

Emerging class of antibiotics to tackle global tuberculosis crisis

Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes…

  • Contains:
  • CharitiesAidWelfare, Medical Health Aged Care
  • 27/02/2026
  • 09:00
Bowel Cancer Australia

Australian age-specific clinical practice guidelines being developed for early-onset bowel cancer

Clinical practice guidelines specifically for young Australians with bowel cancer to be funded by Bowel Cancer Australia and developed in collaboration with the Australian…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.